Search

everythinglearnresearchcommunity

for

Search:↓

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Platelet-rich plasma treatment is more effective and cost-efficient than epinephrine for healing bleeding peptic ulcers, with fewer complications and rebleeding cases.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

GD-23 reduces anxiety by relying on neurosteroid production.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Pilose antler extract helps hair grow in mice with a type of hair loss by speeding up the growth phase.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Letrozole may help prevent seizures by reducing certain hormone levels.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Valproic acid is an effective seizure medication with some temporary side effects.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.